Gastric variceal bleeding is less frequent than esophageal varices bleeding but it still a serious cause of morbidity and mortality. The aim of study was to assess the frequency and identify the patients' outcome after management.
INTRODUCTION
Acute upper gastrointestinal (GI) bleeding is a common cause of emergency hospitalization worldwide 1 .Acute variceal hemorrhage (AVH) is an important complication of portal hypertension (PH) that is associated with significant morbidity and mortality 2 . Gastric variceal bleeding is a serious cause of morbidity and mortality among patients with PH. Most of the studies underestimate their true prevalence 3 . It may be difficult to distinguish fundal varices from gastric folds due to their deep submucosal location as well as the normal color and appearance of the overlaying mucosa 4 .The prevalence of gastric varices (GV) in patients with PH varies from 18 to 70%; although the incidence of bleeding from GV is relatively low ranging from 10 to 36%. Management of GV presents a challenging problem, because since there is no consensus regarding the optimum treatment of GV, treatment tends to be empirical 5 .Sarin et al 6 ., documented that GV were found in 20% of patients with PH and secondary GV developed in 9% of patients during follow-up evaluation.
Although GV bleeding occurs less frequently than esophageal varices (EV) bleeding; it tends to be more severe and requires more blood transfusions with a higher mortality than EV bleeding 6 . Red color spots, larger nodular gastric varices, and fundal location have been identified as risk factors for GV bleeding 7 . In addition, Kim et al 8 . Found that advanced Child-Pugh class, varix>5 mm in size, and the presence of a red spot were associated with an increased risk for a first bleed. As a result of the high morbidity and mortality of GV, it is valuable to estimate its exact frequency and identify risk factors for bleeding among upper Egyptian patients. In addition, evaluation of GV outcome after GV injection.
AIM OF THE WORK
The aim of study was to assess frequency of bleeding GV and identify the patients' outcome after management.
PATIENTS & METHODS
This prospective clinical study was conducted on all cirrhotic patients with upper GIT bleeding seeking medical advice at the Tropical Medicine and Gastroenterology Department, Sohag University Hospital in the period from June 2016 to June 2017.
Inclusion Criteria
Patients with liver cirrhosis and portal hypertension underwent EGD after upper GIT bleeding at the Tropical Medicine and Gastroenterology Department, Sohag University Hospital and diagnosed to have bleeding gastric varices.
Exclusion criteria
Patients diagnosed to have other causes of upper GIT bleeding (such as: EV, peptic ulcer disease, reflux esophagitis, erosions, antral vascular ectasia).
All patients will be subjected to the following:
1-Complete clinical evaluation.
2-Laboratory Investigation:
Complete blood picture, Liver profile serological testing for HBV, and HCV, Serum Creatinine, Ascitic fluid study.
3-Abdominal Ultrasonography :
With details about Size of the liver, surface, hepatic focal lesion, portal vein diameter, portal vein thrombosis, Spleen size, & porto-systemic collaterals and ascites.
4-Upper GIT endoscopy:
Upper endoscopic examination for detailed evaluation of the esophagus, stomach and duodenum.
ETHICAL CONSIDERATION
The study design was approved by the ethical and scientific research committee of Faculty of Medicine, Sohag University. Informed consents were obtained from all patients.
RESULTS
In the endoscopic findings, bleeding from gastric varices was seen in 50 patients (10 %) , bleeding from esophageal varices was detected in 400 patients (80 %), while bleeding from other sources (non variceal _ bleeding) was in 20 patients (4%) as shown in Table ( 1) .The mean age of the studied population was 56.64± 11.06, most of them were males 34 (68 %) Table (2) .The most common etiology for the liver cirrhosis & portal hypertension of the studied group was HCV which was detected in 40 patients (80%) While HBV was detected in 2 patients only (4%) as shown in Table ( Table ( 4) . Bleeding was more common between Child A patients but there were no significant differences as regard child classification or size of varices, also MELD score as shown in Tables (3), (5) . Rate of rebleeding was (22%) , deaths occurred in 19 patients (38%) after admission & eradication of GVs were achieved in 20 (40%)Table (6) .Upon studying the predictors of mortality, we found that they had significantly lower albumin & higher ALT & AST levels with no significant difference as regard ultrasonograghic findings Table (7) . Regarding to child classification & MELD score we found no significant difference between the two groups and these scores could not predict the mortality in our Patients Table (8) .By multivariate analysis we found no independent predictors of mortality or rebleeding in cirrhotic patients with gastric varices as shown in Table ( 12 . The mean age of the studied population was 56.64± 11.06 year, most of them were males 34 (68 %). In another study, out of 205 patients undergoing esophagogastroduodenoscopy, 122(59.5%) were male and 83(40.5%) were female with an overall mean age of 49.5+/-7.49 years 13 .While a total of 41 patients (39 with cirrhosis) underwent 54 cyanoacrylate injections during study period. Mean age was 57 and 73 % were males 14 .It was found by our study that the most common etiology of portal hypertension which led to GV bleeding was liver cirrhosis (100%).Another observational cross-sectional study was conducted from August 2014 to August 2015 at Aziz Bhatti Shaheed Teaching Hospital, Gujrat, Pakistan, using non-probability consecutive sampling. Patients having liver cirrhosis only due to chronic hepatitis C virus, portal vein diameter >12mm or spleen size >12cm in long axis and ascites with no previous history of variceal banding were included. Out of 205 patients undergoing esophagogastroduodenoscopy, 122(59.5%) were male and 83(40.5%) were female with an overall mean age of 49.5+/-7.49 years. Gastric varices were present in 30(14.6%) patients 13 and between January 1998 and January 2010, 97 patients with gastric variceal bleeding underwent endoscopic treatment with a mixture of N-butyl-2-cyanoacrylate and Lipiodol , ninety-one patients had cirrhosis and 6 had noncirrhotic portal hypertension 15 .The medical records of patients who presented with active gastric variceal bleeding between 1998 and 2011 in a tertiary care setting were evaluated retrospectively and the eventual outcome(s) (initial hemostasis, rebleeding, and mortality rate) was assessed at least 1 year after the index bleed ( ninety-seven patients were included) , the mean age of the patients was 51.0 +/-12.5 years; 62% were men.
Hepatitis C was the most common etiology, found in 63 (65%) patients 16 . Our present study showed that the population study who underwent EGD had EV (76%), moderately filled bleeding GVs (74%).Isolated gastric varices type 1& gastroesophogeal varices type 2 had higher bleeding incidence ( 70% , 30% ) respectively .Similar results were reported by Sarin et al., 6 where isolated gastric varices type 1 and gastroesophageal varices type 2 had a significantly higher bleeding incidence (78% and 55% respectively), than gastroesophageal varices type 1 and isolated gastric varices type 2 (10%).However,Mumtaz et al., 11 reported that the incidence of bleeding from isolated gastric varices type 1 was 36% and from gasroesophageal varices type 1, gasroesophageal varices type 2 and isolated gastric varices type 2 were 17.7%, 20.5% and 0% respectively . . Butt et al., 13 show that gastric varices were present in minority of patients undergoing esophagogastroduodenoscopy, and among them gastroesophageal varices type 1 was the most common, while isolated gastric varices type 2 was not present in any patient .Other similar results from Egypt were reported by Thakeb and his college, where isolated gastric varices were accounting for 7.2% and gastroesophageal varices were accounting for 27.1% 17 .In our study, there was also a relation between bleeding from isolated gastric varices and endoscopic signs where bleeding was more in patients with red color signs as reported in 80 % of the cases .The same results were reported by others where they found a significant relation between bleeding from gastric varices and the presence of red color signs 18 . However, there was non statistically significant relation between bleeding gastric varices , MELD & Child scores where bleeding was more in patients with Child class A . This was attributed to small number of the studied population ( 50 patients ) & also limited duration of the study through which data were obtained .This was against other studies , such as the results which were reported by Kim et al., 1997 8 where bleeding from gastric varices was more common in patients with Child class B and C (80% of bleeder) than in patients with Child class A (20% of bleeders) and also that difference was statistically significant. Another author reported Child-Pugh score at presentation for cirrhotic patients was A-12.1 %, B-53.8 %; C-34.1 % and median MELD score at admission was 13 15 . Child-Pugh classification was a significant prognostic factor of survival (P<0.001) 16 , While other reports failed to find a significant relation between bleeding from gastric varices and the severity of liver dysfunction 11 . There were no definite risk factors for bleeding GV as our study didn't have control group to identify them by comparison with the study group, while other studies had. The presence of (ulcers and red color sings) and severe liver dysfunction (Child class B and C) were found to be independent risk factors for bleeding from GV regardless their type, there are many studies reported the same risk factors for bleeding from gastric varices but with minimal differences in between them 8 . In our present study, 40% of the studied population developed eradication 38% died & 22% developed re-bleeding .Histoacryl injection achieved Successful primary hemostasis in all patients with bleeding gastric varices and early rebleeding occurred in only 11 cases (24%).
Secondary hemostasis was achieved in all of them using N-butyl 2 cyanoacrylate (Histoacryl) with no serious complications have been reported. Mumtaz et al., 2007 11 reported that primary hemostasis was achieved with histoacryl injection in 100% of patients and early rebleeding rate was 14%.Mortality was less than our study in others such there were 132 patients with acute GVB (83.3% men, median age 51.3 years) with endoscopic NBC injection treatments recruited. Mortality within 6 weeks was noted in 16.7% patients 19 .In another study, a total of 20 patients (15 male) with PH and GV were enrolled and treated with undiluted NBC injection. The patients were followed clinically and endoscopically for a median of 31 months. Eradication of GV was observed in all patients (13 patients were treated with 1 session and 7 patients with 2 sessions).Overall, GV recurrence was observed in 2 patients (10%), after 6 and 35 mo of follow-up, and GV bleeding rate was 5% (1 patient) 20 .Upon studying the predictors of mortality, we found that they had significantly lower albumin & higher ALT & AST levels with no significant difference as regard ultrasonograghic &endoscopic findings. Regarding to child classification & MELD score we found no significant difference between the two groups and these scores could not predict the mortality in our patients. Impaired renal function, deteriorated liver function with Child pugh score>/= 9 as well as MELD score >/= 18, rebleeding within 5 days, and acute on top liver cell failure are independent predictors of mortality 19 .we found in our study thatearly rebleeding was more common among child A patients with moderately sized GV (F2), but the difference was not statically significant &by multivariate analysis we found that were no independent predictors of rebleeding gastric varices.
Other studies reported that predictors for rebleeding are usually related to the severity of the bleeding and characteristics of the ulcer, whereas advanced age, physical status of the patient, and comorbidities are important predictors for mortality in addition to those for rebleeding 21 .Patients with AVH and MELD score >or = 18, requiring > or = 4 units of PRBCs within the first 24 h or with active bleeding at endoscopy are at increased risk of dying within 6weeks. MELD score > or = 18 is also a strong predictor of variceal re-bleeding within the first 5 days 22 .
Another study reported that re-bleeding within 5 days occurred in 37 patients (15%), MELD score (p = 0.01) and a clot on a varix (p = 0.05) predicted re-bleeding. Patients with a MELD score > or = 18; both MELD score > or = 18 and > or = 4 units of PRBCs transfused; both MELD score > or = 18 and active bleeding at index endoscopy; and variceal re-bleeding had increased risk of death 6 weeks post-AVH 22 .
CONCLUSION
No independent factors could predict the mortality or rebleeding among cirrhotic patients with bleeding GV by multivariate analysis.
